Detalhe da pesquisa
1.
New In Vitro Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial Combinations.
Antimicrob Agents Chemother
; 66(11): e0055622, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36197116
2.
Parasite Viability as a Measure of In Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment.
Antimicrob Agents Chemother
; 66(7): e0011422, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727057
3.
Anti-malarial ozonides OZ439 and OZ609 tested at clinically relevant compound exposure parameters in a novel ring-stage survival assay.
Malar J
; 18(1): 427, 2019 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31849323
4.
Incomplete Plasmodium falciparum growth inhibition following piperaquine treatment translates into increased parasite viability in the in vitro parasite reduction ratio assay.
Front Cell Infect Microbiol
; 14: 1396786, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38746786
5.
In vivo antimalarial efficacy of Artemisia afra powder suspensions.
Phytomedicine
; 129: 155644, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38761524
6.
Next Generation Chemiluminescent Probes for Antimalarial Drug Discovery.
ACS Infect Dis
; 10(4): 1286-1297, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38556981
7.
The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro.
Pharmaceuticals (Basel)
; 16(2)2023 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37009844
8.
Stochastic Protein Alkylation by Antimalarial Peroxides.
ACS Infect Dis
; 5(12): 2067-2075, 2019 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31626733